Over the past day, 27,747 new cases of coronavirus were recorded in all 85 constituent entities of the Russian Federation.
According to the headquarters, in 15% of them the diagnosis was not accompanied by clinical manifestations of the disease.
In the two days preceding this, COVID-19 was detected in 26,513 and 27,002 people.
The total number of confirmed cases of coronavirus infection in Russia reached 3,159,297. Since the beginning of the pandemic, 2,554,340 patients have already recovered, of which 28,922 have been recovered in the last 24 hours.
57,019 people died from complications that developed against the background of coronavirus and related diseases.
Over the last day, 593 deaths were recorded.
The largest number of new cases by region was detected in Moscow (6566), St. Petersburg (3758), Moscow (1487) and Nizhny Novgorod (501) regions.
More than 90.6 million coronavirus tests were carried out in the country, 663 thousand people remain under medical supervision.
According to the capital's headquarters, over the past 24 hours, 1,697 patients with coronavirus have been hospitalized in the city.
There are 560 people on ventilators in Moscow hospitals.
In total, 809,859 cases of COVID-19 were detected in Moscow, 627,368 people recovered, 11,209 patients died.
“Now is a very important period.
This is the first time that the whole country is going to rest for so long, but the situation is not yet unambiguously stable.
This is how we will spend the holidays, this is how we will continue to live until the end of winter ”, - said the chief sanitary doctor of the Russian Federation Anna Popova in an interview with the TV channel“ Russia 1 ”.
Yevgeny Timakov, the head physician of the Leader-Medicine Center, does not exclude that after the end of the New Year holidays, the daily increase in new cases of coronavirus infection in Russia may increase to 40 thousand if citizens neglect safety measures.
“Unfortunately, people do not follow the rules during the holidays.
They will gather in apartments anyway, there will still be an increase in morbidity.
The question here is how much the bulk of the population will pull itself together and try to comply with all the necessary measures, ”TASS quotes him.
© RIA Novosti / Ilya Pitalev
Russia and its citizens will be able to return to a more or less normal lifestyle in the fall of 2021, if at least 50% of the country's population have been vaccinated against coronavirus infection by that time.
This opinion was expressed by the president of the International Association of Specialists in the Field of Infections, former chief freelance specialist of the Ministry of Health of Russia on infectious diseases Irina Shestakova.
“If we now, at least by the fall of 2021, cover (with vaccination. -
RT
) at least 50% (of the population. -
RT
), we will see the results: the number of new cases will sharply decrease, which means that health care, and beds, and we will somehow more or less enter our usual regime, "RIA Novosti quotes her.
In mid-December, a large-scale vaccination against COVID-19 started in all regions of Russia.
For the vaccination campaign, two drugs registered by the Ministry of Health against SARS-CoV-2 are currently being used: the world's first vaccine "Sputnik V", developed by specialists from the Research Center for Electrochemistry and Electronics named after honorary academician N.F.
Hamaleas, and the drug "EpiVacCorona" State Research Center of Virology and Biotechnology "Vector".
In addition, the Federal Medical and Biological Agency (FMBA) of Russia announced that it had received a permit for clinical trials of its drug against coronavirus infection.
“The Ministry of Health of the Russian Federation has conducted an examination of preclinical studies of the drug for the treatment of COVID-19, developed at the FMBA of Russia.
Based on the results of the examination, permission was issued to conduct the first phase of clinical trials.
As part of this phase, it is planned to study the safety and tolerability of the drug in healthy volunteers.
The research will be carried out at the Institute of Immunology of the FMBA of Russia.
At the moment, the testing center is preparing for clinical trials, ”the report says.
It is noted that volunteers are being recruited.
On Wednesday, the head of the FMBA, Veronika Skvortsova, during a meeting with Prime Minister Mikhail Mishustin, emphasized that preclinical studies of this drug have demonstrated its complete safety for the body and its effectiveness exceeding 99%.
“If clinical studies confirm the effectiveness of this drug, it will be the first safe, effective, direct-acting antiviral drug that has no analogues in the world,” Skvortsova said.